ClinicalTrials.Veeva

Menu

Assessment of Peripheral GABA Receptors for Local Pain Relief

A

Aalborg University

Status

Unknown

Conditions

Pain

Treatments

Drug: GABA oral solution
Drug: Pain modulation
Drug: Intramuscular GABA

Study type

Interventional

Funder types

Other

Identifiers

NCT02928328
N-20160037

Details and patient eligibility

About

The effect of peripheral GABAA receptor activation on pain and sensitivity in healthy human subjects has never been investigated. However, as earlier studies suggest that activation of peripheral GABAA receptors is anti-nociceptive in rats, it is important to determine if these findings can be translated into human subjects to determine if peripheral GABAA receptors are a viable target for future analgesic drug development.

Full description

Subproject I This study will test if oral administration of GABA containing solutions will reduce the pain and sensitivity induced by application of capsaicin to the tongue of healthy human subjects. Thirty, pain-free men (n=15) and women (n=15) for the oral cavity study.

Subproject II This study will test the hypothesis that intramuscular injection of GABA alone will not be painful, but will reduce muscle pain sensitivity in healthy human subjects. Thirty, pain-free men (n=15) and women (n=15) will be recruited for the intramuscular GABA injection studies

Subproject III This study will test the hypothesis that intramuscular injection of GABA with glutamate will decrease the intensity of glutamate-evoked muscle pain in healthy human subjects. Thirty, pain-free men (n=15) and women (n=15) will be recruited for the intramuscular glutamate and GABA injection studies.

Enrollment

90 estimated patients

Sex

All

Ages

20 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Aged 20-40 years
  • Free from ongoing or chronic pain
  • Adequate conversational English

Exclusion criteria

  • Pregnancy or intent to become pregnant, breast feeding
  • Signs or symptoms of any serious systemic diseases
  • Current malignancies
  • High blood pressure
  • Requirement for chronic administration of psychiatric, analgesic or other medications that might influence their response to pain
  • Frequent recreational drug or alcohol use
  • Previous neurologic, musculoskeletal or mental illnesses
  • Lack of ability to cooperate

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

90 participants in 3 patient groups

GABA oral solution
Experimental group
Description:
This study will test if oral administration of GABA containing solutions will reduce the pain and sensitivity induced by application of capsaicin to the tongue of healthy human subjects.
Treatment:
Drug: GABA oral solution
Intramuscular GABA
Experimental group
Description:
This study will test the hypothesis that intramuscular injection of GABA alone will not be painful, but will reduce muscle pain sensitivity in healthy human subjects.
Treatment:
Drug: Intramuscular GABA
Pain modulation
Experimental group
Description:
This study will test the hypothesis that intramuscular injection of GABA with glutamate will decrease the intensity of glutamate-evoked muscle pain in healthy human subjects.
Treatment:
Drug: Pain modulation

Trial contacts and locations

1

Loading...

Central trial contact

Brian E Cairns, PhD, DrMed

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems